-
Something wrong with this record ?
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
E. Mejstríková, O. Hrusak, MJ. Borowitz, JA. Whitlock, B. Brethon, TM. Trippett, G. Zugmaier, L. Gore, A. von Stackelberg, F. Locatelli,
Language English Country United States
Document type Letter, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Freely Accessible Science Journals
from 2011-01-28
Nature Open Access
from 2011-01-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
Springer Nature OA/Free Journals
from 2011-01-01
- MeSH
- Antigens, CD19 immunology MeSH
- Child MeSH
- Infant MeSH
- Humans MeSH
- Neoplasm Recurrence, Local immunology pathology MeSH
- Adolescent MeSH
- Biomarkers, Tumor immunology MeSH
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma drug therapy immunology pathology MeSH
- Child, Preschool MeSH
- Antibodies, Bispecific therapeutic use MeSH
- Antineoplastic Agents therapeutic use MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
Charité University Medical Center Berlin Germany
Department of Pediatric Hematology Oncology CLIP Charles University Prague Czech Republic
Department of Pediatric Hematology Robert Debre Hospital Paris France
Global Development Amgen Research GmbH Munich Germany
Hematologic Pathology Johns Hopkins University Baltimore MD USA
Pediatric Oncology Memorial Sloan Kettering Cancer Center New York NY USA
University of Colorado School of Medicine and Children's Hospital Colorado Aurora CO USA
University of Toronto Hospital for Sick Children Toronto ON Canada
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033447
- 003
- CZ-PrNML
- 005
- 20181017150310.0
- 007
- ta
- 008
- 181008s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41408-017-0023-x $2 doi
- 035 __
- $a (PubMed)29259173
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mejstríková, E $u Department of Pediatric Hematology/Oncology, CLIP, Charles University, Prague, Czech Republic.
- 245 10
- $a CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment / $c E. Mejstríková, O. Hrusak, MJ. Borowitz, JA. Whitlock, B. Brethon, TM. Trippett, G. Zugmaier, L. Gore, A. von Stackelberg, F. Locatelli,
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a protilátky bispecifické $x terapeutické užití $7 D018033
- 650 _2
- $a antigeny CD19 $x imunologie $7 D018941
- 650 _2
- $a protinádorové látky $x terapeutické užití $7 D000970
- 650 _2
- $a nádorové biomarkery $x imunologie $7 D014408
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lokální recidiva nádoru $x imunologie $x patologie $7 D009364
- 650 _2
- $a pre-B-buněčná leukemie $x farmakoterapie $x imunologie $x patologie $7 D015452
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hrusak, O $u Department of Pediatric Hematology/Oncology, CLIP, Charles University, Prague, Czech Republic.
- 700 1_
- $a Borowitz, M J $u Hematologic Pathology, Johns Hopkins University, Baltimore, MD, USA.
- 700 1_
- $a Whitlock, J A $u University of Toronto, Hospital for Sick Children, Toronto, ON, Canada.
- 700 1_
- $a Brethon, B $u Department of Pediatric Hematology, Robert Debre Hospital, Paris, France.
- 700 1_
- $a Trippett, T M $u Pediatric Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Zugmaier, G $u Global Development, Amgen Research (Munich) GmbH, Munich, Germany. gerhardz@amgen.com.
- 700 1_
- $a Gore, L $u University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.
- 700 1_
- $a von Stackelberg, A $u Charité University Medical Center, Berlin, Germany.
- 700 1_
- $a Locatelli, F $u Department of Pediatric Hematology-Oncology, IRCCS Ospedale Bambino Gesù, Rome, Italy. University of Pavia, Pavia, Italy.
- 773 0_
- $w MED00187996 $t Blood cancer journal $x 2044-5385 $g Roč. 7, č. 12 (2017), s. 659
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29259173 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181017150809 $b ABA008
- 999 __
- $a ok $b bmc $g 1339462 $s 1030441
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c 12 $d 659 $e 20171220 $i 2044-5385 $m Blood cancer journal $n Blood Cancer J $x MED00187996
- LZP __
- $a Pubmed-20181008